Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions

The high prevalences of antibodies against human T-cell leukemia (lymphotropic) virus type I (HTLV-I) reported for remote populations in Papua New Guinea and the Solomon Islands and for some aboriginal populations in Australia have been verified by virus isolation. Limited genetic analysis of the transmembrane portion (gp21) of the envelope gene of these viruses indicates the existence of highly divergent HTLV-I strains in Melanesia. Here, we report the complete nucleotide sequence of an HTLV-I isolate (designated HTLV-IMEL5) from the Solomon Islands. The overall nucleotide divergence of HTLV-IMEL5 from the prototype HTLV-IATK was approximately 8.5%. The degree of variability in the amino acid sequences of structural genes ranged between 3 and 11% and was higher (8.5 to 25%) for the regulatory (tax and rex) genes and the other genes encoded by the pX region. Since HTLV-IMEL5 was as distantly related to HTLV-II as to the other known HTLV-I strains, it could not have arisen from a reocmbinational event involving HTLV-II but rather might be an example of independent viral evolution in this remote population. These data provide important insights and raise new questions about the origin and global dissemination of HTLV-I.

[1]  M. Reitz,et al.  Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[3]  T. Gojobori,et al.  Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Yoshida,et al.  Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Kaplan,et al.  Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Pavlakis,et al.  Cross-activation of the Rex proteins of HTLV-I and BLV and of the Rev protein of HIV-1 and nonreciprocal interactions with their RNA responsive elements. , 1989, The New biologist.

[7]  R. Weiss,et al.  HTLV-1 envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope. , 1991, Virology.

[8]  J. Berzofsky,et al.  Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells. , 1989, Journal of immunology.

[9]  B. Haynes,et al.  Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. , 1989, Journal of immunology.

[10]  A. Ajdukiewicz,et al.  Comparison between strains of human T lymphotropic virus type I isolated from inhabitants of the Solomon Islands and Papua New Guinea. , 1991, The Journal of infectious diseases.

[11]  K. Nagashima,et al.  A single species of pX mRNA of human T-cell leukemia virus type I encodes trans-activator p40x and two other phosphoproteins , 1986, Journal of virology.

[12]  K. Takatsuki,et al.  Adult T-cell leukemia. , 1995, Internal medicine.

[13]  M. Maki,et al.  Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing , 1988, Cell.

[14]  A. Cann,et al.  Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation , 1985, Nature.

[15]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[16]  G. Shaw,et al.  Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients. , 1991, Virology.

[17]  M. Seiki,et al.  The second pX product p27 x‐III of HTLV‐1 is required for gag gene expression , 1986, FEBS letters.

[18]  L. Ratner,et al.  Nucleotide sequence analysis of isolates of human T-lymphotropic virus type 1 of diverse geographical origins. , 1991, AIDS research and human retroviruses.

[19]  Y. M. Chen,et al.  Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people , 1989, Journal of virology.

[20]  A. Fauci,et al.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease , 1990, Nature.

[21]  M. Malim,et al.  Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action. , 1990, Genes & development.

[22]  G. de Thé,et al.  In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies , 1991, Journal of virology.

[23]  Z. Berneman,et al.  Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Pavlakis,et al.  Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I , 1992, Journal of virology.

[25]  M. Miwa,et al.  Nucleotide sequence analysis of a provirus derived from HTLV-1-associated myelopathy (HAM). , 1988, Molecular biology & medicine.

[26]  R. Garruto,et al.  Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Inoko,et al.  Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. , 1991, International immunology.

[28]  S. Matsushita,et al.  Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Gray,et al.  Envelope gene sequence of HTLV-1 isolate MT-2 and its comparison with other HTLV-1 isolates. , 1990, Virology.

[30]  J. Cruickshank,et al.  Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates , 1990, Journal of virology.

[31]  Y. Tanaka,et al.  Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. , 1991, Journal of immunology.

[32]  M. Sherman,et al.  Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea , 1992, Journal of virology.

[33]  M. Alpers,et al.  Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Sodroski,et al.  A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus. , 1985, Science.

[35]  R. Weiss,et al.  Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins , 1992, Journal of virology.

[36]  T. Copeland,et al.  Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope. , 1986, Journal of Immunology.

[37]  S. Nagataki,et al.  Retrovirus from human T-cell leukemia virus type I-associated myelopathy is the same strain as a prototype human T-cell leukemia virus type I. , 1990, Archives of neurology.

[38]  R. Gallo,et al.  Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations , 1992, Journal of virology.

[39]  M. Yoshida,et al.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Hoeprich,et al.  Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia/lymphotropic virus type I. , 1989, The Journal of biological chemistry.

[41]  M. Maki,et al.  Nucleolar targeting signal of human T-cell leukemia virus type I rex-encoded protein is essential for cytoplasmic accumulation of unspliced viral mRNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Pavlakis,et al.  The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. , 1985, Science.

[43]  T. Quinn,et al.  Comparative analysis of nucleotide sequences of the partial envelope gene (5' domain) among human T lymphotropic virus type I (HTLV-I) isolates. , 1991, Virology.

[44]  J. Coligan,et al.  Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I , 1991, Journal of virology.